229 related articles for article (PubMed ID: 25804946)
1. Anabolic androgenic steroid-induced Takotsubo cardiomyopathy.
Placci A; Sella G; Bellanti G; Margheri M
BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25804946
[TBL] [Abstract][Full Text] [Related]
2. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.
Boyadjiev NP; Georgieva KN; Massaldjieva RI; Gueorguiev SI
J Sports Med Phys Fitness; 2000 Sep; 40(3):271-4. PubMed ID: 11125771
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis of the deltoid muscle in a bodybuilder using anabolic-androgenic steroids: a case report.
Farkash U; Shabshin N; Pritsch Perry M
J Athl Train; 2009; 44(1):98-100. PubMed ID: 19180225
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary embolism associated with the use of anabolic steroids.
Liljeqvist S; Helldén A; Bergman U; Söderberg M
Eur J Intern Med; 2008 May; 19(3):214-5. PubMed ID: 18395167
[TBL] [Abstract][Full Text] [Related]
5. An acute myocardial infarction occurring in an anabolic steroid user.
Huie MJ
Med Sci Sports Exerc; 1994 Apr; 26(4):408-13. PubMed ID: 8201894
[TBL] [Abstract][Full Text] [Related]
6. Brain nerve growth factor unbalance induced by anabolic androgenic steroids in rats.
Pieretti S; Mastriota M; Tucci P; Battaglia G; Trabace L; Nicoletti F; Scaccianoce S
Med Sci Sports Exerc; 2013 Jan; 45(1):29-35. PubMed ID: 22895368
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.
Socas L; Zumbado M; Pérez-Luzardo O; Ramos A; Pérez C; Hernández JR; Boada LD
Br J Sports Med; 2005 May; 39(5):e27. PubMed ID: 15849280
[TBL] [Abstract][Full Text] [Related]
8. Caution for anabolic androgenic steroid use: a case report of multiple organ dysfunction syndrome.
Unai S; Miessau J; Karbowski P; Baram M; Cavarocchi NC; Hirose H
Respir Care; 2013 Dec; 58(12):e159-63. PubMed ID: 23611866
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors.
Elfverson M; Johansson T; Zhou Q; Le Grevès P; Nyberg F
Neuropharmacology; 2011 Dec; 61(7):1172-81. PubMed ID: 21251916
[TBL] [Abstract][Full Text] [Related]
10. Bile acid nephropathy in a bodybuilder abusing an anabolic androgenic steroid.
Luciano RL; Castano E; Moeckel G; Perazella MA
Am J Kidney Dis; 2014 Sep; 64(3):473-6. PubMed ID: 24953892
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of the use of anabolic agents among strength training apprentices in Porto Alegre, RS].
Silva PR; Machado LC; Figueiredo VC; Cioffi AP; Prestes MC; Czepielewski MA
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):104-10. PubMed ID: 17435863
[TBL] [Abstract][Full Text] [Related]
12. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment.
Wesson DW; McGinnis MY
Pharmacol Biochem Behav; 2006 Mar; 83(3):410-9. PubMed ID: 16603236
[TBL] [Abstract][Full Text] [Related]
13. Morphometric study of the corpus cavernosum after anabolic androgenic steroid administration in pubertal and adult rats.
Sena Ade S; Vargas RA; Souza DB; Costa WS; Sampaio FJ
Acta Cir Bras; 2015 Jul; 30(7):478-83. PubMed ID: 26270139
[TBL] [Abstract][Full Text] [Related]
14. Body Image Disorders and Abuse of Anabolic-Androgenic Steroids Among Men.
Pope HG; Khalsa JH; Bhasin S
JAMA; 2017 Jan; 317(1):23-24. PubMed ID: 27930760
[No Abstract] [Full Text] [Related]
15. [Acute paranoid psychotic symptoms after i.m. injection of nandrolone].
Teuber I; Freiwald D; Volz HP
Psychiatr Prax; 2003 May; 30 Suppl 2():S73-4. PubMed ID: 14509043
[TBL] [Abstract][Full Text] [Related]
16. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
[TBL] [Abstract][Full Text] [Related]
17. Extreme hyperbilirubinemia associated with the use of anabolic steroids, health/nutritional supplements, and ethanol: response to ursodeoxycholic acid treatment.
Singh C; Bishop P; Willson R
Am J Gastroenterol; 1996 Apr; 91(4):783-5. PubMed ID: 8677950
[No Abstract] [Full Text] [Related]
18. Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischaemia/reperfusion injury.
Du Toit EF; Rossouw E; Van Rooyen J; Lochner A
Cardiovasc J S Afr; 2005; 16(1):21-8. PubMed ID: 15778771
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyopathy induced by anabolic-androgenic steroid abuse.
Garner O; Iardino A; Ramirez A; Yakoby M
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30037963
[TBL] [Abstract][Full Text] [Related]
20. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
